Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

SLDB

Solid Biosciences Inc

Jan 17 • 04:00PM ET

3.27

Dollar change +0.02
Percentage change 0.62	%

Healthcare • Biotechnology • USA • NASD

Peers: SRPT PFE BMRN BLUE QURE EDIT RGEN NTLA ABEO VYGR

| Held by: VTI IWM VXF IWN IBB VTWO IWC FESM DFAT AVSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.04	Insider Own	18.04%	Shs Outstand	38.93M	Perf Week	-11.14%
Market Cap	130.65M	Forward P/E	-	EPS next Y	-2.90	Insider Trans	-0.44%	Shs Float	32.75M	Perf Month	-28.91%
Income	-102.44M	PEG	-	EPS next Q	-0.79	Inst Own	72.98%	Short Float	6.29%	Perf Quarter	-53.35%
Sales	0.00M	P/S	-	EPS this Y	40.08%	Inst Trans	-8.15%	Short Ratio	5.35	Perf Half Y	-58.08%
Book/sh	4.29	P/B	0.76	EPS next Y	-0.17%	ROA	-51.66%	Short Interest	2.06M	Perf Year	-59.43%
Cash/sh	4.28	P/C	0.76	EPS next 5Y	-	ROE	-65.79%	52W Range	3.03 - 15.05	Perf YTD	-18.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	32.21%	ROI	-54.21%	52W High	-78.27%	Beta	2.03
Dividend TTM	-	Quick Ratio	7.85	Sales past 5Y	-35.14%	Gross Margin	-	52W Low	7.92%	ATR (14)	0.33
Dividend Ex-Date	-	Current Ratio	7.85	EPS Y/Y TTM	34.13%	Oper. Margin	-	RSI (14)	31.18	Volatility	7.32% 8.49%
Employees	88	Debt/Eq	0.15	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.09	Target Price	16.90
Option/Short	Yes / Yes	LT Debt/Eq	0.13	EPS Q/Q	24.51%	Payout	-	Rel Volume	1.29	Prev Close	3.25
Sales Surprise	-	EPS Surprise	-18.23%	Sales Q/Q	-	Earnings	Nov 06 AMC	Avg Volume	384.68K	Price	3.27
SMA20	-15.05%	SMA50	-30.91%	SMA200	-54.90%	Trades		Volume	494,854	Change	0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	Truist	Buy	$16
Dec-13-24	Initiated	Wedbush	Outperform	$16
Dec-10-24	Initiated	JMP Securities	Mkt Outperform	$15
Jul-15-24	Upgrade	JP Morgan	Neutral → Overweight	$10 → $15
Jun-24-24	Upgrade	Leerink Partners	Market Perform → Outperform	$12
May-31-24	Resumed	Piper Sandler	Overweight	$20
Mar-28-24	Initiated	William Blair	Outperform	$40
Mar-15-24	Initiated	Citigroup	Buy	$16
Mar-14-24	Upgrade	Piper Sandler	Neutral → Overweight	$8 → $20
Dec-08-23	Initiated	H.C. Wainwright	Buy	$9
Jul-12-21	Initiated	Piper Sandler	Neutral	$6
May-27-21	Initiated	Jefferies	Buy	$7
Mar-16-21	Upgrade	SVB Leerink	Mkt Perform → Outperform	$3 → $15
Mar-09-21	Initiated	Barclays	Overweight	$13
Jan-08-21	Upgrade	Credit Suisse	Underperform → Neutral	$2 → $7
Jul-28-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
May-07-20	Downgrade	Evercore ISI	Outperform → In-line
Oct-11-19	Initiated	Evercore ISI	Outperform	$22
Aug-29-19	Downgrade	Citigroup	Neutral → Sell	$6
Aug-19-19	Upgrade	SVB Leerink	Mkt Perform → Outperform	$8 → $15

Show Previous Ratings

Jan-15-25 04:05PM	Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines (GlobeNewswire)
Jan-08-25 04:05PM	Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.68%
Jan-07-25 04:15PM	Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia (GlobeNewswire)
Jan-06-25 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-23-24 04:05PM	Solid Biosciences Added to the Nasdaq Biotechnology Index (GlobeNewswire)
01:52PM	Loading…
Dec-13-24 01:52PM	Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst (Benzinga)
Dec-04-24 08:05AM	Solid Biosciences reports inducement grant under Nasdaq listing rule (TipRanks)
08:00AM	Solid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies (GlobeNewswire)
Dec-03-24 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.54%
Nov-26-24 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Nov-14-24 08:00AM	Solid Biosciences to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Nov-06-24 04:05PM	Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) -6.03%
Nov-04-24 08:00AM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-31-24 08:00AM	Solid Biosciences to Participate at the Truist Securities BioPharma Symposium (GlobeNewswire)
Oct-02-24 04:15PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Loading…
Sep-23-24 08:00AM	Solid Biosciences to Participate at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-12-24 08:00AM	Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-04-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-13-24 04:08PM	Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) +14.54%
Aug-05-24 08:00AM	Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-01-24 04:19PM	Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.58%
08:00AM	Solid Biosciences Joins the Russell 3000 Index (GlobeNewswire)
Jun-21-24 07:52AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-04-24 04:00PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-24 06:00AM	3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off (InvestorPlace)
May-15-24 12:53PM	SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024 (InvestorPlace)
07:52AM	Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results (GlobeNewswire)
May-07-24 07:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-02-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.23%
04:05PM	Loading…
Apr-03-24 04:05PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-02-24 10:35AM	Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug (Zacks)
07:20AM	Solid Biosciences' SGT-003 receives rare pediatric disease designation (Pharmaceutical Business Review)
Apr-01-24 07:45AM	Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) -6.61%
Mar-28-24 04:08PM	How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback (Investor's Business Daily) -6.53%
Mar-27-24 07:00AM	Solid Biosciences to Participate at Cantor's Virtual Muscular Dystrophy Symposium (GlobeNewswire) +5.01%
Mar-13-24 07:44AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results (GlobeNewswire) +7.28%
Mar-07-24 07:00AM	Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD (GlobeNewswire) +7.86%
Mar-06-24 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Feb-29-24 03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Jan-17-24 11:27AM	Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up (Zacks)
Jan-16-24 01:10PM	Hedge Fund and Insider Trading News: Anthony Scaramucci, Bill Ackman, Rokos Capital Management, ExodusPoint Capital, Alden Global Capital, Solid Biosciences Inc. (SLDB), and More (Insider Monkey)
08:00AM	Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire)
Jan-15-24 10:18AM	Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why (Zacks)
Jan-08-24 07:09AM	Solid Biosciences Announces $109 Million Private Placement (GlobeNewswire) +7.59%
Jan-04-24 08:00AM	Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-08-23 05:37AM	Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up (Zacks) -12.15%
Dec-07-23 08:00AM	Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003 (GlobeNewswire) +68.42%
Nov-22-23 08:00AM	Solid Biosciences to Participate at 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +9.17%
Nov-16-23 08:29AM	Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND (Zacks)
Nov-14-23 04:05PM	Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003 (GlobeNewswire) +27.93%
Nov-09-23 08:00AM	Solid Biosciences to Participate at Jefferies London Healthcare Conference (GlobeNewswire) -23.66%
Nov-08-23 04:17PM	Solid Biosciences Provides Third Quarter Business Update and Financial Results (GlobeNewswire)
Oct-02-23 08:00AM	Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer (GlobeNewswire)
Sep-20-23 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Sep-05-23 08:56AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-31-23 08:00AM	Solid Biosciences to Participate in Citis 18th Annual BioPharma Conference (GlobeNewswire)
Aug-14-23 04:17PM	Solid Biosciences Provides Second Quarter Business Update and Financial Results (GlobeNewswire)
Jun-01-23 08:00AM	Solid Biosciences to Participate at the Jefferies Healthcare Conference (GlobeNewswire)
May-22-23 08:00AM	Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit (GlobeNewswire)
May-16-23 08:00AM	Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire)
May-11-23 09:35AM	Solid Biosciences Inc. (SLDB) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Solid Biosciences Provides First Quarter Business Update and Financial Results (GlobeNewswire)
May-08-23 04:05PM	Solid Biosciences to Present at JMP Securities Life Sciences Conference (GlobeNewswire) +9.80%
Apr-21-23 08:00AM	Solid Biosciences to Participate in Chardans 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-20-23 10:03AM	Will Alnylam Pharmaceuticals (ALNY) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-19-23 10:01AM	Will Solid Biosciences Inc. (SLDB) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-13-23 08:00AM	Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference (GlobeNewswire)
Mar-25-23 09:44AM	Solid Biosciences Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Mar-23-23 08:00AM	Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results (GlobeNewswire)
Mar-21-23 08:00AM	Solid Biosciences to Participate at BMO Biopharma Spotlight Series: Genetic Medicine Delivery (GlobeNewswire)
Mar-07-23 08:00AM	Solid Biosciences to Present at Barclays Global Healthcare Conference (GlobeNewswire) +5.01%
Mar-02-23 07:52AM	Solid Biosciences Inc.'s (NASDAQ:SLDB) 14% loss last week hit both individual investors who own 51% as well as institutions (Simply Wall St.)
Feb-08-23 08:00AM	Solid Biosciences to Present at SVB Securities Global Biopharma Conference (GlobeNewswire) -5.67%
Jan-26-23 08:00AM	Pathway Development Consortium Announces Publication in Human Gene Therapy on the Application of FDAs Accelerated Approval Pathway for AAV Gene Therapies for Patients with Duchenne Muscular Dystrophy (GlobeNewswire)
Jan-11-23 08:00AM	Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases (GlobeNewswire) +5.04%
Jan-10-23 08:00AM	Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases (GlobeNewswire)
Jan-09-23 04:26PM	Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer (GlobeNewswire)
08:01AM	Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer (GlobeNewswire)
08:00AM	Solid Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-05-22 04:35PM	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:30AM	Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement (GlobeNewswire)
Dec-01-22 04:15PM	Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio (GlobeNewswire)
Nov-22-22 08:00AM	Solid Biosciences to Participate at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-10-22 08:55AM	Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:34AM	Solid Biosciences Provides Third Quarter 2022 Business Update and Financial Results (GlobeNewswire)
Nov-08-22 06:25PM	Adicet Bio, Inc. (ACET) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-01-22 07:55AM	Techne (TECH) Lags Q1 Earnings and Revenue Estimates (Zacks)
Oct-27-22 10:02AM	Analysts Estimate Albireo Pharma (ALBO) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:00AM	Solid Biosciences Announces a 1-for-15 Reverse Stock Split (GlobeNewswire)
Oct-26-22 10:02AM	Earnings Preview: Solid Biosciences Inc. (SLDB) Q3 Earnings Expected to Decline (Zacks)
Oct-20-22 02:41PM	7 Sizzling Stocks That Are Oblivious to the Manic Market (InvestorPlace)
Oct-17-22 11:30AM	Solid Biosciences Touts Encouraging Preclinical Data From Potential Duchenne Gene Therapy (Benzinga)
08:00AM	Solid Biosciences Reports Additional Preclinical Data Demonstrating that its Novel Capsid, AAV-SLB101, Provides Superior Transduction Efficiency and Enhanced Distribution to Skeletal Muscle (GlobeNewswire)
Oct-13-22 08:00AM	Solid Biosciences Presents New SGT-001 IGNITE DMD Study Results at World Muscle Society 2022 Congress Demonstrating Improvements in Ambulatory Function (GlobeNewswire)
Oct-03-22 05:32AM	Ilan Ganot steps back as CEO from the company he founded to save his son (American City Business Journals) +6.09%
Sep-30-22 07:00AM	Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement (GlobeNewswire)
Sep-29-22 08:00AM	Solid Biosciences to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-14-22 08:07AM	Earnings Update: Solid Biosciences Inc. (NASDAQ:SLDB) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts (Simply Wall St.)
Aug-13-22 08:06AM	Analysts' Revenue Estimates For Solid Biosciences Inc. (NASDAQ:SLDB) Are Surging Higher (Simply Wall St.)

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tan Kevin	CFO & Treasurer	Jan 10 '25	Sale	3.89	4,073	15,849	24,789	Jan 13 06:51 PM
Ganot Ilan	Director	Jan 06 '25	Sale	4.31	1,056	4,551	11,445	Jan 07 05:29 PM
Hanrahan Jessie	Chief Regulatory Officer	Dec 03 '24	Sale	5.60	4,610	25,822	14,235	Dec 04 05:34 PM
Howton David T	Officer	Dec 03 '24	Proposed Sale	5.60	5,072	28,396		Dec 04 05:33 PM
Cumbo Alexander	President and CEO	Dec 03 '24	Sale	5.60	11,114	62,236	38,484	Dec 04 05:27 PM
Howton David T	Chief Operating Officer	Dec 03 '24	Sale	5.60	5,072	28,396	15,663	Dec 04 05:04 PM
Herzich Paul	Chief Technology Officer	Dec 03 '24	Sale	5.60	2,777	15,551	12,182	Dec 04 04:42 PM
Cumbo Alexander	Officer	Dec 03 '24	Proposed Sale	5.79	10,687	61,878		Dec 03 05:35 PM
Brooks Gabriel	Chief Medical Officer	Oct 21 '24	Sale	6.50	2,923	19,000	10,979	Oct 22 04:05 PM
Kahn Clare	Director	Jun 07 '24	Buy	7.67	1,100	8,442	1,100	Jun 11 02:15 PM
Ganot Ilan	Director	May 02 '24	Sale	10.33	462	4,772	9,507	May 06 06:48 PM
Ganot Ilan	Director	Jan 29 '24	Sale	7.99	139	1,111	8,416	Jan 30 05:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SLDB

Solid Biosciences Inc

Upgrade your FINVIZ experience